National Institute of Allergy and Infectious Diseases (NIAID): Kidney Failure, Chronic trials
The registry lists 16 Kidney Failure, Chronic studies with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor. 0 are open to participants now and 2 have results posted.
Phase 1 3Phase 2 4Phase 3 2No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Combined Kidney and Bone Marrow Transplantation to Prevent Kidney Transplant RejectionCompletedNCT00801632Phase 2Results posted
- Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation RecipientsCompletedNCT00240994Phase 2Results posted
- A Retrospective Multicenter Study to Determine 5-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-01 StudyCompletedNCT01974999
- Live Kidney Donor Study - Cross-Sectional and Historical Cohort StudyCompletedNCT00951977
- Immune Development in Pediatric Transplantation (IMPACT)CompletedNCT00951353
- Safety of Immunosuppression Minimization in Children and Adolescents After Kidney TransplantationCompletedNCT00768729Phase 1
- Live Kidney Donor StudyCompletedNCT00608283
- Urine Testing to Detect Kidney Transplant RejectionCompletedNCT00337220
- Noninvasive Methods to Monitor Graft Survival in Kidney Transplant PatientsCompletedNCT00308802
- Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%TerminatedNCT00090194Phase 2
- Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow TransplantCompletedNCT00063817Phase 1
- Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney FailureCompletedNCT00062621Phase 1
- Steroid Withdrawal in Pediatric Kidney Transplant RecipientsTerminatedNCT00023244Phase 2
- Pediatric Kidney Transplant Without Calcineurin InhibitorsCompletedNCT00023231Not applicable
- Prevention of Kidney Transplant RejectionCompletedNCT00005010Phase 3
- An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients With End-Stage Renal Disease Who Are Highly Sensitized to Transplant AntigensCompletedNCT00000935Phase 3